Over the past decade considerable progress was made in understanding the molecular changes that occur in heart in response to stress [1] [2] [3] [4] [5] . Specific changes in transcription, for example, were attributed to cardioprotection as an early response to stress in a number of animal models. Recent findings implicate the transcription elongation P-TEFb complex in the compensatory response of the heart to stress [6] [7] [8] Received: March 20, 2008; Accepted: May 30, 2008 
decrease in CLP-1 protein level in heterozygous CLP-1 ϩ/Ϫ mice would influence the response to stress distinct from that in the wild-type CLP-1 ϩ/ϩ heart.
To this end, we used an animal model developed in our laboratory where the CLP-1 gene was ablated [16, 21] . CLP-1 Ϫ/Ϫ mice die in utero during day [16] [17] p.c, however, the heterozygous CLP ϩ/Ϫ mice survive and appear normal phenotypically and serve as a useful model for investigating the role of CLP-1. We, therefore, subjected the CLP-1 ϩ/Ϫ hearts to stress induced by preconditioning, ischemia and ischemia/reperfusion as described before [22] [23] [24] [25] . We found that when the CLP-1 wild-type hearts were subjected to ischaemic stress, the pTEFb complex was activated by releasing the inhibitor CLP-1 protein; however, in the CLP-1 heterozygous mice hearts it remained associated and consequently Pol II phosphorylation was decreased. CLP-1 ϩ/Ϫ hearts also exhibited an increase in the levels of HIF-1␣ during ischemia and ischemia/reperfusion when compared with wild-type CLP-1 hearts. The increase in HIF-1␣ levels is known to trigger the expression of pyruvate dehydrogenase kinase-1 (PDK-1) [26, 27] , as such, we observed an increase in PDK-1 protein in extracts from CLP-1 ϩ/Ϫ hearts. Collectively, these data suggest that CLP-1 heterozygocity in hearts is an important facet of cell protection that is mediated apparently by changes in nuclear transcriptional activity and regulation of genes critical to mitochondrial function. 
and observed that the hearts of CLP-1ϩ/Ϫ mice exhibit pronounced resistance to ischaemic stress. In order to understand the underlying cardioprotective mechanisms, we examined the components of the pTEFb complex as well as the levels of mitochondrial proteins such as, PGC-1␣ and the hypoxia inducible factor 1␣ (HIF-1␣). Both proteins, PGC-1␣ and HIF-1␣, play a significant role in mitochondrial function and cell survival during stress conditions

Material and methods
Animals
Isolated perfused heart preparation
Isolated mice hearts from wild-type littermates and CLP-1 ϩ/Ϫ subjected to ischaemic stress as before [22] were divided into two groups (see Fig. 1A ): (1) 
Measurement of Infarct Size
Following global ischemia, the heart was infused with 10% solution of the triphenyl tetrazolium (TTC) 
Western blotting and Cdk9 kinase assay
The isolated mice hearts used are from four groups (see Fig. 1B 
): (i ) isolated hearts were perfused with KHB buffer for 3 hrs and 45 min. (control); (ii ) the hearts were preconditioned (PC) to ischaemic stress by four cyclic episodes of 5 min ischemia each followed by another 10 min reperfusion; (iii ) the hearts were subjected to 30 min of ischemia followed by 2 hrs reperfusion (I/R) and (iv ) the hearts were subjected first to PC followed by to 30 min of ischemia, followed by 2 hrs of reperfusion (PC/I/R). Heart tissues were homogenized in lysis buffer
Results
Heterozygous CLP-1 hearts are resistant to ischaemic stress
Isolated hearts from CLP-1ϩ/ϩ and CLP-1 ϩ/Ϫ mice were subjected to the experimental stress protocol of ischemia/reperfusion, as shown in Figure 1 and described in 'Materials and Methods'. Functional haemodynamic measurements such ascoronary flow and LVdp/dt were made as before [22] . After reperfusion, the control hearts of CLP-1ϩ/ϩ showed a decrease in the absolute values of aortic flow, developed pressure, and the first derivative of developed pressure (dP/dt max). As expected, preconditioned CLP-1ϩ/ϩ hearts display a recovery following ischemia/reperfusion (see Fig. 2A, D and E (Fig. 2B and C) . Cardioprotection was also evident when the infarct sizes were measured. In the wild-type hearts, the infarct size was reduced upon PC, whereas in the CLP-1ϩ/Ϫ mice the infarct size was the same with or without PC (Fig. 3) . 
Transcription elongation factor-b (P-TEFb) complex and its components
In order to understand the molecular basis of the stressinduced cardioprotection in CLP-1 ϩ/Ϫ hearts, we evaluated the putative changes in the pTEFb complex activity. First the CLP-1 protein levels in CLP-1 ϩ/ϩ and ϩ/Ϫ hearts were examined in control mice by Western blot as shown in Figure 4A .
As expected, the heterozygote hearts have a reduced level of CLP-1 protein (approx. 40%) as compared to wild-type hearts. GAPDH expression served as loading control. We then examined the levels of CLP-1 associated with cyclin-T1 in the P-TEFb complex. Immunoprecipitation with anti-Cdk9 or anti-CLP-1 antibodies was followed by Western blot with anti-cyclin T1 antibody (Fig. 4B). The cyclin-T1-Cdk9 association in the pTEFb complex remained unchanged after each stress in both wildtype and heterozygous hearts. However, the interaction of CLP-1 with cyclin T1 decreased in the heart of wild-type mice subjected to stress, but not in heterozygote hearts under identical conditions. Because CLP-1 is an intrinsic inhibitor of cyclin-T1-mediated Cdk9 activity, its dissociation is required for Cdk9
activity in CLP-1 ϩ/ϩ mice subjected to stress. The lack of CLP-1 dissociation in CLP-1 ϩ/Ϫ hearts suggests that cdk9 activity would be inhibited. We, therefore, examined the Cdk9 activity in extracts of the same hearts of heterozygous CLP-1 ϩ/Ϫ mice and found that it was markedly reduced compared to the activity level in wild-type CLP-1 ϩ/ϩ hearts subjected to identical stress (Fig. 4C) [17, 18] . Figure 4D shows that there was a significant decrease in both serine5 and serine2 phosphorylation in the heart extracts from CLP-1 ϩ/Ϫ mice subjected to IR or PC and IR induced stress (see Discussion). [17, 18] . We, therefore, examined whether the converse is true, i.e. whether the repressed level of Cdk9 activity in CLP-1 ϩ/Ϫ mice would enhance PGC-1␣ level. As seen in Figure  5A , the PGC-1 expression was noticeably enhanced in CLP-1 ϩ/Ϫ heart subjected to stress. The increase in the level of PGC-1 suggests that the mitochondrial viability and function must have been enhanced. Mitochondria are intimately involved in cellular oxygen sensing. Since the activation of the hypoxia-induced transcription factor, HIF-1␣, serves as an index of mitochondrial activity [26, 27] we examined the protein level of HIF-1␣ in CLP-1 ϩ/Ϫ heart subjected to stress. Western blot analysis showed that there was a significant increase in the levels of HIF-1␣ protein in CLP-1 ϩ/Ϫ hearts subjected to ischaemic stress as compared to CLP-1 ϩ/ϩ hearts treated identically (Fig. 5B) . HIF-1␣ degradation is mediated by ubiquitination [23] . Therefore, it is likely that the enhanced level of HIF-1␣ is due to inhibition of ubiquitination. We, therefore, immunoprecipitated the heart extracts using anti-ubiquitin antibody (Fig. 5C) . We observed the characteristic profile of ubiquitination of HIF-1␣ under each stress condition in CLP-1 ϩ/ϩ hearts, but the same was significantly diminished in heterozygous CLP-1 ϩ/Ϫ hearts. It was suggested that sumoylation is an additional post-translational mechanism that targets HIF-1␣ protein and influences its expression level in hypoxic condition [27] . When HIF-1 was immunoprecipitated followed by Western blotting with antibody against SUMO-1, there was an increase in HIF-1␣/SUMO-1 interaction in extracts from heterozygous CLP-1 ϩ/Ϫ hearts (Fig. 5D ). The lower panel shows HIF-1␣ as loading control when equal amounts of HIF-1 were used for each stress column. There was also an increase in the expression of SUMO-1 protein in the heart of CLP-1 ϩ/Ϫ mice (Fig. 5E ). Since HIF-1 expression during hypoxic conditions is known to induce pyruvate dehydrogenase kinase-1 (PDK-1), which facilitates cell adaptation to low oxygen pressure by repressing mitochondrial function and reactive oxygen species (ROS) production [28, 29] , we examined PDK-1 expression and found it to be increased in CLP-1 ϩ/Ϫ hearts (Fig. 5F ).
CLP-1 regulates mitochondrial genes
It was reported recently that the increase in Cdk7 and Cdk9 activities such as that occurs in compensatory cardiac hypertrophy, causes down-regulation of PGC-1␣, a master regulator of mitochondrial genes
Discussion
In [24, 26] [27, 28] . Enhanced expression of HIF-1␣ is thus expected to provide protection against ischaemic injury [32] [33] . Indeed, CLP-1 protein is known to interact with both positive and negative transcription factors in addition to the components of the pTEFb complex [34] . Our data here point to a novel mechanism for cardioprotection against ischaemic stress that conceptually involves specific alterations rendered by the Pol II inhibitor protein CLP-1 in the nuclear and mitochondrial gene expression program.
